Prestige BioPharma950210 
$10.05-1.89%24h
-1.89%24h
Global rank10381
Market cap$601.28M
Change 7d-7.29%
YTD Performance41.26%
SP500 benchmarkOutperform
P/E0.03
P/S4987.94
Revenue$120.55K
Earnings-$2.13M
Dividend yield-
Prestige BioPharma 950210 Total Debt
950210 Total Debt in 2022: $38.37M
According to Prestige BioPharma latest financial reports the total debt is $38.37M, an increase of 1839.71% to 2022. At the end of 2022 company had $1.98M total debt. This figure represents the debts and financial obligations that Prestige BioPharma combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Prestige BioPharma 950210 Total Debt History from 2023 to 2022
-
Value:-
950210 Total Debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023 | $38.37M | 1839.71% |
| 2022 | $1.98M | -25.63% |
| 2021 | $2.66M | 46.69% |
| 2020 | $1.81M | - |
View the Top Total Debt Stocks 
